PerkinElmer Q1 Revenues up 5 Percent; Increases 2014 EPS Guidance | GenomeWeb

NEW YORK (GenomeWeb) – PerkinElmer said after the close of the market on Thursday that its first quarter revenues were up 5 percent year over year.

The Waltham, Mass.-based company said that for the three months ended March 30, revenues grew to $531.9 million from $505.4 million in the year-ago quarter, edging out the consensus analyst estimate of $531.3 million.

Its Human Health segment posted a 6 percent increase in revenue year over year to $299.5 million from $281.3 million, while its Environmental Health segment grew 4 percent to $232.4 million from $224.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.